XV4-31561-43108
3 vaccinations
4 coded responses
38 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 622 / IL
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Registered in v-safe
-
2021-02-12
Dose 1 — Moderna
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-16
-
2021-02-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: Redness, ItchingMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-05
-
2021-03-12
Dose 2 — Moderna
- 2021-03-12
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-06-13
-
2021-09-10
Survey response — 6 month, dose 2MedDRA: Dyspnoea exertional, Fatigue, Pre-existing disease — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
-
2021-10-29
Dose 3 — Moderna
- 2021-10-29
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
-
2021-11-26
Survey response — 28 day, dose 3MedDRA: Abnormal sensation in eye, Eye disorder, Facial nerve disorder, Sensory disturbance, Tic, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11 · check-in answers available
-
2021-11-26
Report sent to call center — 28 day, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2021-12-01
-
2021-12-02
Call successfulCompleted over the phone
- 2021-12-03
- 2021-12-10
- 2022-01-28
- 2022-04-29
-
2022-10-29
Survey response — 12 month, dose 3MedDRA: Macular hole, Metamorphopsia, Office visit, Vision blurred — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11 · check-in answers available
-
2022-10-29
Report sent to call center — 12 month, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Moderna | |
| 2 | 2021-03-12 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-26 | Successful 2021-12-02 |
Completed over the phone |
| 2022-10-29 | Unsuccessful |
Free text
Release 4
Systemic reaction (other): Slight burning and aching at injection sight
Release 9
Symptoms: Fatigue, tire more easily.Shortness of breath upon exertionI had covid in August 2020 my symotoms are perhaps due to covid
Release 10
Symptoms: I am having some issues with my left facial nerve. I have a persistent tic of my left eye with an altered sensation of my forehead eye and cheek
Healthcare visit (other): Appointment with my primary physician 11/27
Release 12
Symptoms: Blurred and distorted vision: a hole in my macula
Healthcare visit (other): In office visits with retina specialist
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abnormal sensation in eye | · | · | ✓ |
| SD | Dyspnoea exertional | · | · | ✓ |
| SD | Eye disorder | · | · | ✓ |
| SD | Facial nerve disorder | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Macular hole | · | · | ✓ |
| SD | Metamorphopsia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Sensory disturbance | · | · | ✓ |
| SD | Tic | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release